DEA Controlled Substances (The "Orange Book")
Notes: Several drugs may share the same CSCN (Controlled Substance Code Number). Some drugs do not have a CSCN assigned. The 'opioid' class includes opiates and opium derivatives. The 'hallucinogen' class includes psychedelic substance.
Visit https://deadiversion.usdoj.gov/schedules/schedules.html to view related Abbreviations and descriptions of each schedule criteria. The complete "Orange Book" is available at https://deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf
CSCN | Drug | Class | CSA Schedule | Narcotic | Other Names |
---|---|---|---|---|---|
7014 | (1-(4-Fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone | cannabimimetic agent | I | N | FUB-144 |
7458 | 1-(1-Phenylcyclohexyl)pyrrolidine | hallucinogen | I | N | PCPy, PHP, rolicyclidine |
9663 | 1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine | opioid | I | Y | PEPAP, synthetic heroin |
7083 | 1-(5-Fluoropentyl)-N-(2-phenylpropan-2-yl)-1H-indazole-3-carboxamide | cannabimimetic agent | I | N | 5F-CUMYL-PINACA; SGT-25 |
4000 | 1-androstenediol (3α,17β-dihydroxy-5α-androst-1-ene) | steroid | III | N | |
4000 | 1-androstenediol (3β,17β-dihydroxy-5α-androst-1-ene) | steroid | III | N | |
4000 | 1-androstenedione (5α-androst-1-en-3,17-dione) | steroid | III | N | |
9661 | 1-Methyl-4-phenyl-4-propionoxypiperidine | opioid | I | Y | MPPP, synthetic heroin |
7460 | 1-Phenylcyclohexylamine | precursor | II | N | PCP precursor |
8603 | 1-Piperidinocyclohexanecarbonitrile | precursor | II | N | PCC, PCP precursor |
7470 | 1-[1-(2-Thienyl)cyclohexyl]piperidine | hallucinogen | I | N | TCP, tenocyclidine |
7473 | 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine | hallucinogen | I | N | TCPy |
4000 | 13β-ethyl-17β-hydroxygon-4-en-3-one | steroid | III | N | |
4000 | 17α-methyl-3α,17β-dihydroxy-5α-androstane | steroid | III | N | |
4000 | 17α-methyl-3β,17β-dihydroxy-5α-androstane | steroid | III | N | |
4000 | 17α-methyl-3β,17β-dihydroxyandrost-4-ene | steroid | III | N | |
4000 | 17α-methyl-4-hydroxynandrolone (17α-methyl-4-hydroxy-17β-hydroxyestr-4-en-3-one) | steroid | III | N | |
4000 | 17α-methyl-5α-androstan-17β-ol | steroid | III | N | |
4000 | 17α-methyl-androst-2-ene-3,17β-diol | steroid | III | N | |
4000 | 17α-methyl-androsta-1,4-diene-3,17β-diol | steroid | III | N | |
4000 | 17α-methyl-androstan-3-hydroxyimine-17β-ol | steroid | III | N | |
4000 | 17α-methyl-Δ1-dihydrotestosterone (17β-hydroxy-17α-methyl-5α-androst-1-en-3-one) | steroid | III | N | 17α-methyl-1-testosterone |
4000 | 17β-hydroxy-androstano[2,3-d]isoxazole | steroid | III | N | |
4000 | 17β-hydroxy-androstano[3,2-c]isoxazole | steroid | III | N | |
4000 | 18a-homo-3-hydroxy-estra-2,5(10)-dien-17-one | steroid | III | N | |
4000 | 19-nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione) | steroid | III | N | |
4000 | 19-nor-4-androstenediol (3α,17β-dihydroxyestr-4-ene) | steroid | III | N | |
4000 | 19-nor-4-androstenediol (3β,17β-dihydroxyestr-4-ene) | steroid | III | N | |
4000 | 19-nor-4-androstenedione (estr-4-en-3,17-dione) | steroid | III | N | |
4000 | 19-nor-5-androstenediol (3α,17β-dihydroxyestr-5-ene) | steroid | III | N | |
4000 | 19-nor-5-androstenediol (3β,17β-dihydroxyestr-5-ene) | steroid | III | N | |
4000 | 19-nor-5-androstenedione (estr-5-en-3,17-dione) | steroid | III | N | |
9861 | 2',5'-Dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide) | I | Y | ||
9855 | 2'-Fluoro ortho-fluorofentanyl (N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide; also known as 2'-fluoro 2-fluorofentanyl) | opioid | I | Y | |
7348 | 2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) | hallucinogen | I | N | 2C-T-7 (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2)) |
7399 | 2,5-Dimethoxy-4-ethylamphetamine | hallucinogen | I | N | DOET (Positional Isomer: 1-(2,5-dimethoxy-4- methylphenyl)butan-2-amine) |
7396 | 2,5-Dimethoxyamphetamine | hallucinogen | I | N | DMA, 2,5-DMA |
7524 | 2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C-P) | hallucinogen | I | N | 2C-P |
7509 | 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E) | hallucinogen | I | N | 2C-E (Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G)) |
7508 | 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D) | hallucinogen | I | N | 2C-D |
7521 | 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N) | hallucinogen | I | N | 2C-N |
7517 | 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) | hallucinogen | I | N | 2C-H |
7536 | 2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25B-NBOMe) | I | N | 25B-NBOMe, 2C-B-NBOMe, 25B, Cimbi-36 | |
7519 | 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C) | hallucinogen | I | N | 2C-C |
7537 | 2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25C-NBOMe) | I | N | 25C-NBOMe, 2C-C-NBOMe, 25C, Cimbi-82 | |
7385 | 2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2) | hallucinogen | I | N | 2C-T-2 |
7518 | 2-(4-iodo-2,5-dimethoxyphenyl) ethanamine (2C-I) | hallucinogen | I | N | 2C-I |
7538 | 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) | I | N | 25I-NBOMe, 2C-I-NBOMe, 25I, Cimbi-5 | |
7532 | 2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine(2C-T-4) | hallucinogen | I | N | 2C-T-4 (Positional Isomer: 2,5-Dimethoxy-4- ethylthioamphetamine (Aleph-2)) |
7286 | 2-(ethylamino)-2-(3-methoxyphenyl)cyclohexan-1-one(methoxetamine) | I | N | MXE, methoxetamine | |
9825 | 2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide | opioid | I | Y | Methoxyacetyl fentanyl |
9664 | 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one | I | Y | ||
4000 | 2α,17α-dimethyl-17β-hydroxy-5β-androstan-3-one | steroid | III | N | |
4000 | 2α,3α-epithio-17α-methyl-5α-androstan-17β-ol | steroid | III | N | |
7390 | 3,4,5-Trimethoxyamphetamine | hallucinogen | I | N | TMA (Positional Isomers: 2,4,5-Trimethoxy-amphetamine (TMA-5), 2,4,6-Trimethoxy-amphetamine (TMA-6), Escaline) |
7404 | 3,4-Methylenedioxy-N-ethylamphetamine | hallucinogen | I | N | N-ethyl MDA, MDE, MDEA (Positional Isomer: MDMB) |
7400 | 3,4-Methylenedioxyamphetamine | hallucinogen | I | N | MDA, Love Drug |
7405 | 3,4-Methylenedioxymethamphetamine | hallucinogen | I | N | MDMA, Ecstasy, XTC |
1233 | 3-Fluoro-N-methylcathinone (3-FMC) | stimulant | I | N | 1-(3-fluorophenyl)-2-(methylamino)propan-1-one) (Positional Isomer: 2-FMC) |
9860 | 3-Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide) | I | Y | ||
9813 | 3-Methylfentanyl | opioid | I | Y | China White, fentanyl |
1259 | 3-methylmethcathinone (2-(methylamino)-1-(3-methylphenyl)propan-1-one) | hallucinogen | I | N | 3-MMC; 3-methylmethcathinone |
9833 | 3-Methylthiofentanyl | opioid | I | Y | China White, fentanyl |
4000 | 3α,17β-dihydroxy-5α-androstane | steroid | III | N | |
4000 | 3β,17β-dihydroxy-5α-androstane | steroid | III | N | |
4000 | 3β-hydroxy-estra-4,9,11-trien-17-one | steroid | III | N | |
7443 | 4'-chloro-alpha-pyrrolidinovalerophenone (4-chloro-α-PVP) | stimulant | I | N | 4-chloro-α-PVP; 4'-chloro-α- pyrrolidinopentiophenone; 1-(4-chlorophenyl)-2- (pyrrolidin-1-yl)pentan-1-one) |
9819 | 4'-Methyl acetyl fentanyl (N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide) | opioid | I | Y | |
1595 | 4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4-methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine) | I | N | ||
4000 | 4-androstenediol (3β,17β-dihydroxy-androst-4-ene) | steroid | III | N | 4-AD |
4000 | 4-androstenedione (androst-4-en-3,17-dione) | steroid | III | N | |
8333 | 4-Anilino-N-phenethyl-4-piperidine (ANPP) | precursor | II | N | ANPP, Despropionyl fentanyl |
7391 | 4-Bromo-2,5-dimethoxyamphetamine | hallucinogen | I | N | DOB, 4-bromo-DMA |
7392 | 4-Bromo-2,5-dimethoxyphenethylamine | hallucinogen | I | N | 2C-B, Nexus, has been sold as Ecstasy, i.e. MDMA |
4000 | 4-chloro-17α-methyl-17β-hydroxy-androst-4-en-3-one | steroid | III | N | |
4000 | 4-chloro-17α-methyl-17β-hydroxy-androst-4-ene-3,11-dione | steroid | III | N | |
4000 | 4-chloro-17α-methyl-androst-4-ene-3β,17β-diol | steroid | III | N | |
4000 | 4-chloro-17α-methyl-androsta-1,4-diene-3,17β-diol | steroid | III | N | |
7089 | 4-CN-CUMYL-BUTINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)-1 H-indazole-3-carboxamide) | cannabimimetic agent | I | N | 4-cyano-CUMYL-BUTINACA; 4-CN-CUMYL BINACA; CUMYL-4CN-BINACA; SGT-78 |
4000 | 4-dihydrotestosterone (17β-hydroxy-androstan-3-one) | steroid | III | N | Anabolex, Andractim, Pesomax, Stanolone |
1238 | 4-Fluoro-N-methylcathinone (4-FMC) | stimulant | I | N | flephedrone; 1-(4-fluorophenyl)-2- (methylamino)propan-1-one) (Positional Isomer: 2-FMC) |
9824 | 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | opioid | I | Y | Para-fluoroisobutyryl fentanyl |
4000 | 4-hydroxy-19-nortestosterone (4,17β-dihydroxyestr-4-en-3-one) | steroid | III | N | |
4000 | 4-hydroxy-androst-4-ene-3,17-dione | steroid | III | N | Listed as 4-Hydroxy-androst-4-ene-3,17-dione[3,2- c]pyrazole-5α-androstan-17β-ol |
4000 | 4-hydroxytestosterone (4,17β-dihydroxyandrost-4-en-3-one) | steroid | III | N | |
7411 | 4-Methoxyamphetamine | hallucinogen | I | N | PMA |
7395 | 4-Methyl-2,5-dimethoxyamphetamine | hallucinogen | I | N | DOM, STP (Positional Isomer: 2,5-Dimethoxy-3,4- dimethylphenethylamine (2C-G)) |
7245 | 4-methyl-alpha-ethylaminopentiophenone (4-MEAP) | stimulant | I | N | 4-MEAP; 2-(ethylamino)-1-(4-methylphenyl)pentan-1- one) |
7498 | 4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) | stimulant | I | N | MePPP, 4-methyl-α-pyrrolidinopropiophenone, 1-(4- methylphenyl)-2-(pyrrolidin-1-yl)-propan-1-one) |
1249 | 4-Methyl-N-ethylcathinone (4-MEC) | stimulant | I | N | 2-(ethylamino)-1-(4-methylphenyl)propan-1-one) (Positional Isomers: 3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4- dimethylmethcathinone(3,4-DMMC),N- ethylbuphedrone (NEB),N-ethyl-N- methylcathinone( |
1590 | 4-Methylaminorex (cis isomer) | stimulant | I | N | U4Euh, McN-422 |
7043 | 4F-MDMB-BINACA (4F-MDMB-BUTINACA or methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | I | N | ||
7091 | 4F-MDMB-BUTICA (methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate | I | N | 4F-MDMB-BUTICA; 4F-MDMB-BICA | |
7446 | 4´-methyl-alpha-pyrrolidinohexiophenone (MPHP) | stimulant | I | N | MPHP; 4'-methyl-alpha-pyrrolidinohexanophenone; 1- (4-methylphenyl)-2-(pyrrolidin-1-yl)hexan-1-one) |
4000 | 5-androstenediol (3β,17β-dihydroxy-androst-5-ene) | steroid | III | N | |
4000 | 5-androstenedione (androst-5-en-3,17-dione) | steroid | III | N | |
7011 | 5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone | cannabimimetic agent | I | N | 5-Fluoro-UR-144, XLR-11 and XLR11 |
7401 | 5-Methoxy-3,4-methylenedioxyamphetamine | hallucinogen | I | N | MMDA |
7439 | 5-Methoxy-N,N-diisopropyltryptamine | hallucinogen | I | N | 5-MeO-DIPT (Positional Isomer: 5-Methoxy-N,N- dipropyltryptamine (5-MeO-DPT)) |
7431 | 5-Methoxy-N,N-dimethyltryptamine | hallucinogen | I | N | 5-MeO-DMT (Positional Isomer: 4-Methoxy-N,N- dimethyltryptamine (4-MeO-DMT)) |
7025 | 5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1 H-indazole-3-carboxamide) | cannabimimetic agent | I | N | |
7085 | 5F-CUMYL-P7AICA (1-(5-fluoropentyl)-N-(2-phenylpropan-2-yl)-1 H-pyrrolo[2,3-b]pyridine-3-carboxamide) | cannabimimetic agent | I | N | |
7094 | 5F-EDMB-PICA (ethyl 2-[[1-(5-fluorophentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate | I | N | 5F-EDMB-PICA; 5F-EDMB-2201 | |
7225 | 5F-PB-22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) | cannabimimetic agent | I | N | 5-Fluoro-PB-22; 5F-PB-22 |
7034 | 5F–ADB; 5F–MDMB–PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | cannabimimetic agent | I | N | 5F-ADB, 5F-MDMB-PINACA, (Positional isomer: 5F-AEB, 5F-EMB-PINACA) |
7033 | 5F–AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) | cannabimimetic agent | I | N | 5F-AMB |
7049 | 5F–APINACA, 5F–AKB48 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | 5F-APINACA, 5F-AKB48 |
4000 | 5α-androstan-3,17-dione | steroid | III | N | androstanedione |
4000 | 5α-androstan-3,6,17-trione | steroid | III | N | |
4000 | 6-bromo-androsta-1,4-diene-3,17-dione | steroid | III | N | |
4000 | 6-bromo-androstan-3,17-dione | steroid | III | N | |
4000 | 6α-methyl-androst-4-ene-3,17-dione | steroid | III | N | |
7031 | AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide | cannabimimetic agent | I | N | AB-CHMINACA |
7012 | AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | AB-FUBINACA |
7023 | AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | AB-PINACA |
9319 | Acetorphine | cannabimimetic agent | I | Y | |
9821 | Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) | opioid | I | Y | |
9815 | Acetyl-alpha-methylfentanyl | opioid | I | Y | |
9051 | Acetyldihydrocodeine | cannabimimetic agent | I | Y | Acetylcodone |
9601 | Acetylmethadol | opioid | I | Y | Methadyl acetate |
9811 | Acryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide) | opioid | I | Y | Acryloylfentanyl |
7092 | ADB-4en-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxamide) | I | N | ADB-4en-PINACA | |
7027 | ADB-BUTINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | ADB-BUTINACA |
7035 | ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | ADB-PINACA |
7010 | ADB–FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | ADB-FUBINACA |
9551 | AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide)) | opioid | I | Y | AH-7921 |
2731 | Alfaxalone | depressant | IV | N | Alfaxan, 5α-pregnan-3α-ol-11,20-dione |
9737 | Alfentanil | opioid | II | Y | Alfenta |
9602 | Allylprodine | opioid | I | Y | |
9864 | alpha'-Methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | I | Y | ||
7249 | Alpha-ethyltryptamine | hallucinogen | I | N | ET, Trip |
9814 | Alpha-methylfentanyl | opioid | I | Y | China White, fentanyl |
9832 | Alpha-methylthiofentanyl | opioid | I | Y | China White, fentanyl |
7432 | Alpha-methyltryptamine | hallucinogen | I | N | AMT (Positional Isomer: N-Methyltryptamine) |
7546 | alpha-pyrrolidinobutiophenone (α-PBP) | stimulant | I | N | 1-phenyl-2-(pyrrolidin-1-yl)butan-1-one) |
7548 | alpha-pyrrolidinoheptaphenone (PV8) | stimulant | I | N | PV8; 1-phenyl-2-(pyrrolidin-1-yl)heptan-1-one) |
7544 | alpha-pyrrolidinohexanophenone (α-PHP) | stimulant | I | N | α-PHP; α-pyrrolidinohexanophenone; 1-phenyl-2- (pyrrolidin-1-yl)hexan-1-one) |
7545 | alpha-pyrrolidinopentiophenone (α-PVP) | stimulant | I | N | α-pyrrolidinovalerophenone, 1-phenyl-2- (pyrrolidin-1- yl)pentan-1-one) (Positional Isomers: 4-methyl-α- pyrrolidinobutiophenone (4-MePBP), 1-phenyl-2- (piperidin-1-yl)butan-1-one) |
9603 | Alphacetylmethadol except levo-alphacetylmethadol | opioid | I | Y | |
9604 | Alphameprodine | opioid | I | Y | |
9605 | Alphamethadol | opioid | I | Y | |
9010 | Alphaprodine | opioid | II | Y | Nisentil |
2882 | Alprazolam | depressant | IV | N | Xanax |
7694 | AM-694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) | cannabimimetic agent | I | N | AM-694 |
7201 | AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) | cannabimimetic agent | I | N | AM2201 |
1219 | Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) | I | N | ||
1585 | Aminorex | stimulant | I | N | has been sold as methamphetamine |
2125 | Amobarbital | depressant | II | N | Amytal, Tuinal |
2126 | Amobarbital & noncontrolled active ingred. | III | N | ||
2126 | Amobarbital suppository dosage form | III | N | ||
1100 | Amphetamine | stimulant | II | N | Dexedrine, Adderall, Obetrol |
4000 | anabolic steroids | steroid | III | N | Any substance meeting the definition of anabolic steroid as set forth in 21 CFR 1300.01 |
9020 | Anileridine | opioid | II | Y | Leritine |
7048 | APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide | cannabimimetic agent | I | N | APINACA and AKB48 |
2100 | Aprobarbital | depressant | III | N | Alurate |
2145 | Barbital | depressant | IV | N | Veronal, Plexonal, barbitone |
2100 | Barbituric acid derivative | depressant | III | N | Barbiturates not specifically listed |
9606 | Benzethidine | opioid | I | Y | |
1228 | Benzphetamine | stimulant | III | N | Didrex, Inapetyl |
9052 | Benzylmorphine | cannabimimetic agent | I | Y | |
9842 | beta'-Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide; also known as β'-phenylfentanyl; 3-phenylpropanoyl fentanyl) | opioid | I | Y | |
9831 | Beta-hydroxy-3-methylfentanyl | opioid | I | Y | China White, fentanyl |
9830 | Beta-hydroxyfentanyl | opioid | I | Y | China White, fentanyl |
9836 | Beta-hydroxythiofentanyl | opioid | I | Y | N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]- N-phenylpropionamide, N-[1-[2-hydroxy-2-(2- thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide |
9856 | beta-Methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide; also knownas β-methyl fentanyl) | opioid | I | Y | |
9607 | Betacetylmethadol | opioid | I | Y | |
9608 | Betameprodine | opioid | I | Y | |
9609 | Betamethadol | opioid | I | Y | |
9611 | Betaprodine | opioid | I | Y | |
9800 | Bezitramide | opioid | II | Y | Burgodin |
4000 | bolasterone (7α,17α-dimethyl-17β-hydroxyandrost-4-en-3-one) | steroid | III | N | |
4000 | boldenone (17β-hydroxyandrost-1,4-diene-3-one) | steroid | III | N | Equipoise, Parenabol, Vebonol, dehydrotestosterone |
4000 | boldione (androsta-1,4-diene-3,17-dione) | steroid | III | N | |
2400 | Brexanolone (3α-hydroxy-5α-pregnan-20-one) | depressant | IV | N | Allopregnanolone |
2710 | Brivaracetam | other | V | N | BRV, UCB-34714, Briviact, ((2S)-2-[(4R)-2-oxo-4- propylpyrrolidin-1-yl] butanamide) |
2748 | Bromazepam | depressant | IV | N | Lexotan, Lexatin, Lexotanil |
9098 | Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one) | opioid | I | Y | 1-[1-[1-(4-bromophenyl)ethyl]-4-piperidinyl]-1,3- dihydro-2H-benzimidazol-2-one) |
7433 | Bufotenine | hallucinogen | I | N | Mappine, N,N-dimethylserotonin |
9064 | Buprenorphine | hallucinogen | III | Y | Buprenex, Temgesic, Subutex, Suboxone |
2100 | Butabarbital (secbutabarbital) | depressant | III | N | Butisol, Butibel |
2100 | Butalbital | depressant | III | N | Fiorinal, Butalbital with aspirin |
2100 | Butobarbital (butethal) | depressant | III | N | Soneryl (UK) |
9751 | Butonitazene (2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) | I | Y | ||
9720 | Butorphanol | other | IV | N | Stadol, Stadol NS, Torbugesic, Torbutrol |
7541 | Butylone | stimulant | I | N | bk-MBDB; 1-(1,3-benzodioxol-5-yl)-2- (methylamino)butan-1-one) (Positional Isomers: dimethylone (bk-MDDMA; MDDMC), N,N-dimethyl-3,4- methylenedioxycathinone) |
9822 | Butyryl Fentanyl | opioid | I | Y | N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide, N- (1-phenethylpiperidin-4-yl)-N-phenylbutanamide |
4000 | calusterone (7β,17α-dimethyl-17β-hydroxyandrost-4-en-3-one) | steroid | III | N | Methosarb |
2749 | Camazepam | depressant | IV | N | Albego, Limpidon, Paxor |
9743 | Carfentanil | opioid | II | Y | Wildnil |
8192 | Carisoprodol | depressant | IV | N | Soma |
1230 | Cathine | stimulant | IV | N | Constituent of "Khat" plant, (+)-norpseudoephedrine |
1235 | Cathinone | stimulant | I | N | Constituent of "Khat" plant |
2720 | Cenobamate [(1R)-1-(2-chlorophenyl)-2-(tetrazol-2-yl)ethyl]carbamate | other | V | N | 2H-tetrazole-2-ethanol, alpha-(2-chlorophenyl)-, carbamate (ester), (alphaR)-; carbamic acid (R)-(+)-1- (2-chlorophenyl)-2-(2H-tetrazol-2-yl)ethyl ester) |
2460 | Chloral betaine | depressant | IV | N | Beta Chlor |
2465 | Chloral hydrate | depressant | IV | N | Noctec |
2744 | Chlordiazepoxide | depressant | IV | N | Librium, Libritabs, Limbitrol, SK-Lygen |
2510 | Chlorhexadol | depressant | III | N | Mechloral, Mecoral, Medodorm, Chloralodol |
1645 | Chlorphentermine | stimulant | III | N | Pre-Sate, Lucofen, Apsedon, Desopimon |
2751 | Clobazam | depressant | IV | N | Urbadan, Urbanyl |
2737 | Clonazepam | depressant | IV | N | Klonopin, Clonopin |
2786 | Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | I | N | ||
9612 | Clonitazene | opioid | I | Y | |
2768 | Clorazepate | depressant | IV | N | Tranxene |
1647 | Clortermine | stimulant | III | N | Voranil |
4000 | clostebol (4-chloro-17β-hydroxyandrost-4-en-3-one) | steroid | III | N | Alfa-Trofodermin, Clostene, 4-chlorotestosterone |
2752 | Clotiazepam | depressant | IV | N | Trecalmo, Rize, Clozan, Veratran |
2753 | Cloxazolam | depressant | IV | N | Akton, Lubalix, Olcadil, Sepazon |
9040 | Coca Leaves | stimulant | II | Y | |
9041 | Cocaine | stimulant | II | Y | Methyl benzoylecgonine, Crack |
9050 | Codeine | opioid | II | Y | Morphine methyl ester, methyl morphine |
9803 | Codeine & isoquinoline alkaloid 90 mg/du | hallucinogen | III | Y | Codeine with papaverine or noscapine |
9804 | Codeine combination product 90 mg/du | hallucinogen | III | Y | Empirin,Fiorinal,Tylenol,ASA or APAP w/codeine |
9070 | Codeine methylbromide | cannabimimetic agent | I | Y | |
n/a | Codeine preparations - 200 mg/(100 ml or 100 gm) | opioid | V | Y | Cosanyl,Robitussin A-C,Cheracol,Cerose,Pediacof |
9053 | Codeine-N-oxide | cannabimimetic agent | I | Y | |
7297 | CP-47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexy]-phenol) | cannabimimetic agent | I | N | CP-47,497 |
7298 | CP-47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl]-phenol) | cannabimimetic agent | I | N | CP-47,497 C8 Homologue |
9844 | Crotonyl fentanyl ((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide) | opioid | I | Y | |
7093 | CUMYL-PEGACLONE (5-pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one) | I | N | CUMYL-PEGACLONE; SGT-151 | |
9847 | Cyclopentyl fentanyl | opioid | I | Y | N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopentanecarboxamide |
9845 | Cyclopropyl Fentanyl | opioid | I | Y | N-(1-phenethylpiperidin-4-yl)-N- phenylcyclopropanecarboxamide |
9054 | Cyprenorphine | cannabimimetic agent | I | Y | |
2410 | Daridorexant [(S)-2-(5-chloro-4-methyl-1H benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl](5-methoxy-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone | depressant | IV | N | QUVIVIQ |
4000 | dehydrochloromethyltestosterone (4-chloro-17β-hydroxy-17α-methyl-androst-1,4-dien-3-one) | steroid | III | N | Oral-Turinabol |
2754 | Delorazepam | depressant | IV | N | |
9055 | Desomorphine | cannabimimetic agent | I | Y | |
4000 | desoxymethyltestosterone (17α-methyl-5α-androst-2-en-17β-ol) | steroid | III | N | Madol |
9613 | Dextromoramide | opioid | I | Y | Palfium, Jetrium, Narcolo |
9278 | Dextropropoxyphene dosage forms | narcotic | IV | Y | Darvon, propoxyphene, Darvocet, Propacet |
9273 | Dextropropoxyphene, bulk (non-dosage forms) | opioid | II | Y | Propoxyphene |
9615 | Diampromide | opioid | I | Y | |
2765 | Diazepam | depressant | IV | N | Valium, Diastat |
2467 | Dichloralphenazone | depressant | IV | N | Midrin, dichloralantipyrine |
2789 | Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one | I | N | ||
1610 | Diethylpropion | stimulant | IV | N | Tenuate, Tepanil |
9616 | Diethylthiambutene | opioid | I | Y | |
7434 | Diethyltryptamine | hallucinogen | I | N | DET, N,N-Diethyltryptamine (Positional Isomer: N-Methyl-N-isopropyltryptamine (MiPT)) |
9168 | Difenoxin | opioid | I | Y | Lyspafen |
9167 | Difenoxin 1 mg/25 ug AtSO4/du | narcotic | IV | Y | Motofen |
n/a | Difenoxin preparations - 0.5 mg/25 ug AtSO4/du | opioid | V | Y | Motofen |
9120 | Dihydrocodeine | opioid | II | Y | Didrate, Parzone |
9807 | Dihydrocodeine combination product 90 mg/du | hallucinogen | III | Y | Synalgos-DC, Compal |
n/a | Dihydrocodeine preparations 100mg/(100 ml or 100gm) | opioid | V | Y | Cophene-S, various others |
9334 | Dihydroetorphine | opioid | II | Y | DHE |
9145 | Dihydromorphine | cannabimimetic agent | I | Y | |
9617 | Dimenoxadol | opioid | I | Y | |
9618 | Dimepheptanol | opioid | I | Y | |
9619 | Dimethylthiambutene | opioid | I | Y | |
7435 | Dimethyltryptamine | hallucinogen | I | N | DMT |
9621 | Dioxaphetyl butyrate | opioid | I | Y | |
9170 | Diphenoxylate | opioid | II | Y | |
n/a | Diphenoxylate preparations 2.5 mg/25 ug AtSO4 | opioid | V | Y | Lomotil, Logen |
9622 | Dipipanone | opioid | I | Y | Dipipan, phenylpiperone HCl, Diconal, Wellconal |
7369 | Dronabinol (synthetic) in sesame oil in soft gelatincapsule as approved by FDA | hallucinogen | III | N | Marinol, synthetic THC in sesame oil/soft gelatin as approved by FDA |
7365 | Dronabinol in an oral solution in a drug productapproved for marketing by the U.S. Food and DrugAdministration | hallucinogen | II | N | Syndros |
4000 | drostanolone (17β-hydroxy-2α-methyl-5α-androstan-3-one) | steroid | III | N | Drolban, Masterid, Permastril |
9335 | Drotebanol | cannabimimetic agent | I | Y | Metebanyl, oxymethebanol |
9180 | Ecgonine | stimulant | II | Y | Cocaine precursor, in Coca leaves |
9725 | Eluxadoline | other | IV | N | VIBERZI |
2020 | Embutramide | depressant | III | N | Tributane |
2756 | Estazolam | depressant | IV | N | ProSom, Domnamid, Eurodin, Nuctalon |
4000 | estra-4,9,11-triene-3,17-dione | steroid | III | N | |
2540 | Ethchlorvynol | depressant | IV | N | Placidyl |
2545 | Ethinamate | depressant | IV | N | Valmid, Valamin |
7036 | Ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate | cannabimimetic agent | I | N | 5F-EDMB-PINACA |
2758 | Ethyl loflazepate | depressant | IV | N | |
4000 | ethylestrenol (17α-ethyl-17β-hydroxyestr-4-ene) | steroid | III | N | Maxibolin, Orabolin, Durabolin-O, Duraboral |
9623 | Ethylmethylthiambutene | opioid | I | Y | |
9190 | Ethylmorphine | opioid | II | Y | Dionin |
9808 | Ethylmorphine combination product 15 mg/du | hallucinogen | III | Y | |
n/a | Ethylmorphine preparations 100 mg/(100 ml or 100 gm) | opioid | V | Y | |
7547 | Ethylone | I | N | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)propan-1-one; 3,4-methylenedioxy-N-ethylcathinone; bk-MDEA; MDEC | |
2780 | Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine | I | N | ||
9765 | Etodesnitazene; etazene (2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) | I | Y | ||
9624 | Etonitazene | opioid | I | Y | |
9056 | Etorphine (except HCl) | cannabimimetic agent | I | Y | |
9059 | Etorphine HCl | opioid | II | Y | M 99 |
9625 | Etoxeridine | opioid | I | Y | |
7549 | Eutylone | I | N | 1-(1,3-benzodioxol-5-yl)-2-(ethylamino)butan-1-one, bk-EBDB | |
2779 | Ezogabine | other | V | N | Potiga |
1760 | Fencamfamin | stimulant | IV | N | Reactivan |
1503 | Fenethylline | stimulant | I | N | Captagon,amfetyline,ethyltheophylline amphetamine |
1575 | Fenproporex | stimulant | IV | N | Gacilin, Solvolip |
9801 | Fentanyl | opioid | II | Y | Duragesic, Oralet, Actiq, Sublimaze, Innovar |
9851 | Fentanyl carbamate (ethyl (1-phenethylpiperidin-4-yl)(phenyl)carbamate) | opioid | I | Y | |
9850 | Fentanyl related-substances as defined in 21 CFR1308.11(h) | I | Y | ||
2785 | Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) | I | N | ||
2788 | Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine | I | N | 8-bromo-6-(2-fluorophenyl)-1-methyl-4H- [1,2,4]triazolo[4,3-a][1,4]benzodiazepine | |
2759 | Fludiazepam | depressant | IV | N | |
9756 | Flunitazene (N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | I | Y | ||
2763 | Flunitrazepam | depressant | IV | N | Rohypnol, Narcozep, Darkene, Roipnol |
4000 | fluoxymesterone (9-fluoro-17α-methyl-11β,17β-dihydroxyandrost-4-en-3-one) | steroid | III | N | Anadroid-F, Halotestin, Ora-Testryl |
2767 | Flurazepam | depressant | IV | N | Dalmane |
4000 | formebolone (2-formyl-17α-methyl-11α,17β-dihydroxyandrost-1,4-dien-3-one) | steroid | III | N | Esiclene, Hubernol |
2138 | Fospropofol | depressant | IV | N | Lusedra |
9834 | Furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-2-carboxamide) | opioid | I | Y | |
4000 | furazabol (17α-methyl-17β-hydroxyandrostano[2,3-c]-furazan) | steroid | III | N | Frazalon, Miotolon, Qu Zhi Shu |
9626 | Furethidine | opioid | I | Y | |
2010 | Gamma Hydroxybutyric Acid | depressant | I | N | GHB, gamma hydroxybutyrate, sodium oxybate |
2012 | Gamma Hydroxybutyric Acid preparations | depressant | III | N | Xyrem |
2401 | Ganaxolone (3α-hydroxy-3β-methyl-5α-pregnan-20-one) | other | V | N | |
2550 | Glutethimide | depressant | II | N | Doriden, Dorimide |
2762 | Halazepam | depressant | IV | N | Paxipam |
2771 | Haloxazolam | depressant | IV | N | |
9200 | Heroin | cannabimimetic agent | I | Y | Diacetylmorphine, diamorphine |
9193 | Hydrocodone | opioid | II | Y | dihydrocodeinone |
9301 | Hydromorphinol | cannabimimetic agent | I | Y | |
9150 | Hydromorphone | opioid | II | Y | Dilaudid, dihydromorphinone |
9627 | Hydroxypethidine | opioid | I | Y | |
7260 | Ibogaine | hallucinogen | I | N | Constituent of "Tabernanthe iboga" plant |
9827 | Isobutyryl fentanyl | opioid | I | Y | N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide |
9226 | Isomethadone | opioid | II | Y | Isoamidone |
9614 | Isotonitazene (N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | opioid | I | Y | N,N-diethyl-2-[[4-(1-methylethoxy)phenyl]methyl]-5- nitro-1H-benzimidazole-1-ethanamine |
9862 | Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide) | I | Y | ||
7118 | JWH-018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) | cannabimimetic agent | I | N | JWH-018 and AM-678 |
7019 | JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) | cannabimimetic agent | I | N | JWH-019 |
7173 | JWH-073 (1-Butyl-3-(1-naphthoyl)indole) | cannabimimetic agent | I | N | JWH-073 |
7081 | JWH-081 (1-Pentyl-3-(1-(4-methoxynaphthoyl)indole) | cannabimimetic agent | I | N | JWH-081 |
7122 | JWH-122 (1-Pentyl-3-(4-methyl-1-naphthoyl)indole) | cannabimimetic agent | I | N | JWH-122 |
7200 | JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) | cannabimimetic agent | I | N | JWH-200 |
7203 | JWH-203 (1-Pentyl-3-(2-chlorophenylacetyl)indole) | cannabimimetic agent | I | N | JWH-203 |
6250 | JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl)indole) | cannabimimetic agent | I | N | JWH-250 |
7398 | JWH-398 (1-Pentyl-3-(4-chloro-1-naphthoyl)indole) | cannabimimetic agent | I | N | JWH-398 |
7285 | Ketamine | depressant | III | N | Ketaset, Ketalar, Special K, K |
2772 | Ketazolam | depressant | IV | N | Anxon, Loftran, Solatran, Contamex |
9628 | Ketobemidone | opioid | I | Y | Cliradon |
2746 | Lacosamide | other | V | N | Vimpat |
2790 | Lasmiditan [2,4,6-trifluoro-N-(6-(1-methylpiperidine-4-carbonyl)pyridine-2-yl-benzamide] | other | V | N | Reyvow |
2245 | Lemborexant | depressant | IV | N | (1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2- (3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane- 1-carboxamide |
9648 | Levo-alphacetylmethadol | opioid | II | Y | LAAM, long acting methadone, levomethadyl acetate |
9210 | Levomethorphan | opioid | II | Y | |
9629 | Levomoramide | opioid | I | Y | |
9631 | Levophenacylmorphan | opioid | I | Y | |
9220 | Levorphanol | opioid | II | Y | Levo-Dromoran |
1205 | Lisdexamfetamine | stimulant | II | N | Vyvanse |
2773 | Loprazolam | depressant | IV | N | |
2885 | Lorazepam | depressant | IV | N | Ativan |
1625 | Lorcaserin | lorcaserin | IV | N | Belviq |
2774 | Lormetazepam | depressant | IV | N | Noctamid |
7300 | Lysergic acid | depressant | III | N | LSD precursor |
7310 | Lysergic acid amide | depressant | III | N | LSD precursor |
7315 | Lysergic acid diethylamide | hallucinogen | I | N | LSD, lysergide |
7032 | MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) | cannabimimetic agent | I | N | MAB-CHMINACA and ADB-CHMINACA |
7360 | Marihuana | hallucinogen | I | N | Cannabis, marijuana |
7350 | Marihuana Extract | I | N | ||
1605 | Mazindol | stimulant | IV | N | Sanorex, Mazanor |
7090 | MDMB-4en-PINACA (methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate) | I | N | MDMB-4en-PINACA | |
7042 | MDMB–CHMICA, MMB–CHMINACA (Methyl 2-(1-(cyclohexylmethyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) | cannabimimetic agent | I | N | MDMB-CHMICA, MMB-CHMINACA |
7020 | MDMB–FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) | cannabimimetic agent | I | N | MDMB-FUBINACA (Positional Isomer: EMB-FUBINACA) |
7535 | MDPV (3,4-Methylenedioxypyrovalerone) | hallucinogen | I | N | MDPV (Positional Isomers: 1-(1,3-benzodioxol-5-yl)-2- (cyclohexylamino)propan-1-one(n-cyclohexyl methylone or 3,4-methylenedioxy-α- cyclohexylaminopropiophenone) ; 1-(1,3-benzodioxol- 4-yl)-2-(pyrrolidin-1-yl)pentan-1-one (2,3- methylenedioxy pyrovalerone |
2800 | Mebutamate | depressant | IV | N | Capla |
2572 | Mecloqualone | depressant | I | N | Nubarene |
2836 | Medazepam | depressant | IV | N | Nobrium |
1580 | Mefenorex | stimulant | IV | N | Anorexic, Amexate, Doracil, Pondinil |
9230 | Meperidine | opioid | II | Y | Demerol, Mepergan, pethidine |
9232 | Meperidine intermediate-A | opioid | II | Y | Meperidine precursor |
9233 | Meperidine intermediate-B | opioid | II | Y | Meperidine precursor, normeperidine |
9234 | Meperidine intermediate-C | opioid | II | Y | Meperidine precursor |
1248 | Mephedrone (4-Methyl-N-methylcathinone) | hallucinogen | I | N | 4-MMC (Positional Isomers: 3-Methyl-methcathinone, Buphedrone, Ethcathinone, N,N-Dimethyl-cathinone) |
2820 | Meprobamate | depressant | IV | N | Miltown, Equanil, Micrainin, Equagesic, Meprospan |
7381 | Mescaline | hallucinogen | I | N | Constituent of "Peyote" cacti |
1227 | Mesocarb (N-phenyl-N'-(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) | I | N | ||
4000 | mestanolone (17α-methyl-17β-hydroxy-5α-androstan-3-one) | steroid | III | N | Assimil, Ermalone, Methybol, Tantarone |
4000 | mesterolone (1α-methyl-17β-hydroxy-5α-androstan-3-one) | steroid | III | N | Androviron, Proviron, Testiwop |
9857 | meta-Fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) | I | Y | ||
9858 | meta-Fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | I | Y | ||
9240 | Metazocine | opioid | II | Y | |
9250 | Methadone | opioid | II | Y | Dolophine, Methadose, Amidone |
9254 | Methadone intermediate (4-cyano-2-dimethylamino-4,4-diphenylbutane) | opioid | II | Y | Methadone precursor |
1105 | Methamphetamine | stimulant | II | N | Desoxyn, D-desoxyephedrine, ICE, Crank, Speed |
4000 | methandienone (17α-methyl-17β-hydroxyandrost-1,4-dien-3-one) | steroid | III | N | Dianabol, Metabolina, Nerobol, Perbolin |
4000 | methandriol (17α-methyl-3β,17β-dihydroxyandrost-5-ene) | steroid | III | N | Sinesex, Stenediol, Troformone |
2565 | Methaqualone | depressant | I | N | Quaalude, Parest, Somnafac, Opitimil, Mandrax |
4000 | methasterone (2α,17α-dimethyl-5α-androstan-17β-ol-3-one) | steroid | III | N | Methasterone; androstan-3-one |
1237 | Methcathinone | stimulant | I | N | N-Methylcathinone, "cat" |
4000 | methenolone (1-methyl-17β-hydroxy-5α-androst-1-en-3-one) | steroid | III | N | Primobolan, Primobolan Depot, Primobolan S |
1478 | Methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine) | I | N | ||
2264 | Methohexital | depressant | IV | N | Brevital |
7021 | Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3-methylbutanoate | cannabimimetic agent | I | N | FUB–AMB, MMB– FUBINACA, AMB–FUBINACA |
7041 | Methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate | cannabimimetic agent | I | N | 5F-MDMB-PICA (Positional Isomer: 5F-EMB-PICA or 5-fluoro-EMB- PICA) |
9302 | Methyldesorphine | cannabimimetic agent | I | Y | |
4000 | methyldienolone (17α-methyl-17β-hydroxyestra-4,9(10)-dien-3-one) | steroid | III | N | |
9304 | Methyldihydromorphine | cannabimimetic agent | I | Y | |
7540 | Methylone (3,4-Methylenedioxy-N-methylcathinone) | hallucinogen | I | N | (Positional Isomer: 2,3- methylenedioxymethcathinone (2,3-MDMC, 1- (benzo[d][1,3]dioxol-4-yl)-2-(methylamino)propan-1- one)) |
1724 | Methylphenidate | stimulant | II | N | Concerta, Ritalin, Methylin |
2250 | Methylphenobarbital (mephobarbital) | depressant | IV | N | Mebaral, mephobarbital |
4000 | methyltestosterone (17α-methyl-17β-hydroxyandrost-4-en-3-one) | steroid | III | N | Android, Oreton, Testred, Virilon |
4000 | methyltrienolone (17α-methyl-17β-hydroxyestra-4,9,11-trien-3-one) | steroid | III | N | Metribolone |
2575 | Methyprylon | depressant | III | N | Noludar |
9764 | Metodesnitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) | I | Y | ||
9757 | Metonitazene (N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) | opioid | I | Y | |
9260 | Metopon | opioid | II | Y | |
4000 | mibolerone (7α,17α-dimethyl-17β-hydroxyestr-4-en-3-one) | steroid | III | N | Cheque, Matenon |
2884 | Midazolam | depressant | IV | N | Versed |
7044 | MMB-CHMICA, AMB-CHMICA (methyl 2-(1-(cyclohexylmethyl)-1 H-indole-3-carboxamido)-3-methylbutanoate) | cannabimimetic agent | I | N | |
7095 | MMB-FUBICA (methyl 2-(1-(4-fluorobenzyl)-1H-indole-3-carboxamido)-3-methyl butanoate | I | N | MMB-FUBICA | |
1680 | Modafinil | stimulant | IV | N | Provigil |
9802 | Moramide-intermediate | opioid | II | Y | |
9632 | Morpheridine | opioid | I | Y | |
9300 | Morphine | opioid | II | Y | MS Contin, Roxanol, Oramorph, RMS, MSIR |
9810 | Morphine combination product/50 mg/(100 ml or 100gm) | hallucinogen | III | Y | |
9305 | Morphine methylbromide | cannabimimetic agent | I | Y | |
9306 | Morphine methylsulfonate | cannabimimetic agent | I | Y | |
9307 | Morphine-N-oxide | cannabimimetic agent | I | Y | |
9560 | MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine)) | opioid | I | Y | MT-45 |
9308 | Myrophine | cannabimimetic agent | I | Y | |
1480 | N,N-Dimethylamphetamine | stimulant | I | N | |
9843 | N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide | opioid | I | Y | Tetrahydrofuranyl fentanyl |
9816 | N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide | opioid | I | Y | Ortho-fluorofentanyl or 2-fluorofentanyl |
7047 | N-(Adamantan-1-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide | cannabimimetic agent | I | N | FUB-AKB48; FUB-APINACA; AKB48 N-(4- FLUOROBENZYL) |
7493 | N-Benzylpiperazine | stimulant | I | N | BZP, 1-benzylpiperazine |
9760 | N-desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxylbenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amin) | I | Y | ||
7455 | N-Ethyl-1-phenylcyclohexylamine | hallucinogen | I | N | PCE |
7482 | N-Ethyl-3-piperidyl benzilate | hallucinogen | I | N | JB 323 |
1475 | N-Ethylamphetamine | stimulant | I | N | NEA |
7246 | N-ethylhexedrone | stimulant | I | N | α-ethylaminohexanophenone; 2-(ethylamino)-1- phenylhexan-1-one) |
7543 | N-Ethylpentylone (1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-pentan-1-one) | stimulant | I | N | Ephylone (Positional Isomers: 3,4-methylenedioxy-α- propylaminobutiophenone; N,N-dimethylpentylone) |
7402 | N-Hydroxy-3,4-methylenedioxyamphetamine | hallucinogen | I | N | N-hydroxy MDA |
7484 | N-Methyl-3-piperidyl benzilate | hallucinogen | I | N | JB 336 |
9761 | N-piperidinyl etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl-1H-benzimidazole) | I | Y | etonitazepipne | |
9758 | N-pyrrolidino etonitazene (2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole) | I | Y | etonitazepyne | |
7379 | Nabilone | hallucinogen | II | N | Cesamet |
9400 | Nalorphine | other | III | Y | Nalline |
4000 | nandrolone (17β-hydroxyestr-4-en-3-one) | steroid | III | N | Deca-Durabolin, Durabolin, Durabolin-50 |
1258 | Naphyrone | stimulant | I | N | naphthylpyrovalerone; 1-(naphthalen-2-yl)-2- (pyrrolidin-1-yl)pentan-1-one) (Positional Isomer: α-naphyrone) |
9309 | Nicocodeine | cannabimimetic agent | I | Y | |
9312 | Nicomorphine | cannabimimetic agent | I | Y | Vilan |
2837 | Nimetazepam | depressant | IV | N | Erimin |
2834 | Nitrazepam | depressant | IV | N | Mogadon |
7221 | NM2201; CBL2201 (Naphthalen-1-yl 1-(5-fluoropentyl)-1 H-indole-3-carboxylate) | cannabimimetic agent | I | N | |
9633 | Noracymethadol | opioid | I | Y | |
4000 | norbolethone (13β,17α-diethyl-17β-hydroxygon-4-en-3-one) | steroid | III | N | Genabol |
4000 | norclostebol (4-chloro-17β-hydroxyestr-4-en-3-one) | steroid | III | N | Anabol-4-19, Lentabol |
2838 | Nordiazepam | depressant | IV | N | Nordazepam, Demadar, Madar |
4000 | norethandrolone (17α-ethyl-17β-hydroxyestr-4-en-3-one) | steroid | III | N | Nilevar, Pronabol, Solevar |
8366 | Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) | precursor | II | Y | |
9634 | Norlevorphanol | opioid | I | Y | |
9635 | Normethadone | opioid | I | Y | Phenyldimazone |
4000 | normethandrolone (17α-methyl-17β-hydroxyestr-4-en-3-one) | steroid | III | N | Lutenin, Matronal, Orgasteron |
9313 | Normorphine | cannabimimetic agent | I | Y | |
9668 | Noroxymorphone | opioid | II | Y | |
9636 | Norpipanone | opioid | I | Y | |
9838 | Ocfentanil | opioid | I | Y | N-(2-fluorophenyl)-2-methoxy-N-(1- phenethylpiperidin-4-yl)acetamide |
9245 | Oliceridine (N-[(3-methoxythiophen-2-yl)methyl] ({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro [4.5]decan-9-yl]ethyl{time} )amine fumarate) | opioid | II | Y | |
9809 | Opium combination product 25 mg/du | hallucinogen | III | Y | Paregoric, other combination products |
9610 | Opium extracts | opioid | II | Y | |
9620 | Opium fluid extract | opioid | II | Y | |
9650 | Opium poppy | II | Y | Papaver somniferum | |
n/a | Opium preparations - 100 mg/(100 ml or 100 gm) | opioid | V | Y | Parepectolin, Kapectolin PG, Kaolin Pectin P.G. |
9630 | Opium tincture | opioid | II | Y | Laudanum |
9640 | Opium, granulated | opioid | II | Y | Granulated opium |
9639 | Opium, powdered | opioid | II | Y | Powdered opium |
9600 | Opium, raw | opioid | II | Y | Raw opium, gum opium |
9330 | Oripavine | opioid | II | Y | |
9852 | ortho-Fluoroacryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide) | opioid | I | Y | |
9846 | ortho-Fluorobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide; also known as 2-fluorobutyryl fentanyl) | opioid | I | Y | |
9863 | ortho-Fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | I | Y | ||
9853 | ortho-Fluoroisobutyryl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) | opioid | I | Y | |
9848 | ortho-Methyl acetylfentanyl (N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide; also known as 2-methyl acetylfentanyl) | opioid | I | Y | |
9820 | ortho-Methyl methoxyacetyl fentanyl (2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) | opioid | I | Y | 2-methyl methoxyacetyl fentanyl |
4000 | oxandrolone (17α-methyl-17β-hydroxy-2-oxa-5α-androstan-3-one) | steroid | III | N | Anavar, Lonavar, Oxandrin, Provitar, Vasorome |
2835 | Oxazepam | depressant | IV | N | Serax, Serenid-D |
2839 | Oxazolam | depressant | IV | N | Serenal, Convertal |
9143 | Oxycodone | opioid | II | Y | OxyContin, Percocet, Endocet, Roxicodone, Roxicet, |
4000 | oxymesterone (17α-methyl-4,17β-dihydroxyandrost-4-en-3-one) | steroid | III | N | Anamidol, Balnimax, Oranabol, Oranabol 10 |
4000 | oxymetholone (17α-methyl-2-hydroxymethylene-17β-hydroxy-5α-androstan-3-one) | steroid | III | N | Anadrol-50, Adroyd, Anapolon, Anasteron, Pardroyd |
9652 | Oxymorphone | opioid | II | Y | Numorphan |
9826 | Para-chloroisobutyryl fentanyl | opioid | I | Y | N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4- yl)isobutyramide |
9854 | Para-Fluoro furanyl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | opioid | I | Y | |
9823 | Para-fluorobutyryl fentanyl | opioid | I | Y | N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4- yl)butyramide |
9812 | Para-Fluorofentanyl | opioid | I | Y | China White, fentanyl |
9837 | Para-methoxybutyryl fentanyl | opioid | I | Y | N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4- yl)butyramide |
9859 | para-Methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide) | I | Y | ||
1245 | Para-Methoxymethamphetamine (PMMA), 1-(4-methoxyphenyl)-N-methylpropan-2-amine | I | N | ||
9865 | para-Methylcyclopropylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide) | I | Y | ||
9817 | Para-Methylfentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide; also known as 4-methylfentanyl) | opioid | I | Y | |
7374 | Parahexyl | hallucinogen | I | N | Synhexyl |
2585 | Paraldehyde | depressant | IV | N | Paral |
7222 | PB-22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) | cannabimimetic agent | I | N | QUPIC; PB-22 |
1530 | Pemoline | stimulant | IV | N | Cylert |
9709 | Pentazocine | other | IV | N | Talwin, Talwin NX, Talacen, Talwin Compound |
1246 | Pentedrone (α-methylaminovalerophenone) | stimulant | I | N | 2-(methylamino)-1-phenylpentan-1-one) (Positional Isomers: 3-methylethcathinone (3-MEC), 4-ethylmethcathinone (4-EMC), 4-methylbuphedrone (4-MeMABP;4-MeBP), 3,4-dimethylmethcathinone (3,4-DMMC),N-ethylbuphedrone (NEB),N-ethyl-N- methylcathinone(EMC)) |
2270 | Pentobarbital | depressant | II | N | Nembutal |
2271 | Pentobarbital & noncontrolled active ingred. | III | N | FP-3 | |
2271 | Pentobarbital suppository dosage form | III | N | WANS | |
7542 | Pentylone | stimulant | I | N | bk-MBDP; 1-(1,3-benzodioxol-5-yl)-2- (methylamino)pentan-1-one) (Positional Isomers: dibutylone (bk-DMBDB) and propylone (3',4'-methylenedioxy-N- propylaminocathinone; 1-(benzo[d][1,3]dioxol-5-yl)-2- (propylamino)propan-1-one); 2,3-methylenedioxy-α- ethyl |
2261 | Perampanel | depressant | III | N | Fycompa, [2-(2-oxo-l-phenyl- 5-pyridin-2-yl-l ,2-dihydropyridin-3-yl) benzonitrile ] |
2591 | Petrichloral | depressant | IV | N | Pentaerythritol chloral, Periclor |
7415 | Peyote | hallucinogen | I | N | Cactus which contains mescaline |
9637 | Phenadoxone | opioid | I | Y | |
9638 | Phenampromide | opioid | I | Y | |
9715 | Phenazocine | opioid | II | Y | Narphen, Prinadol |
7471 | Phencyclidine | depressant | II | N | PCP, Sernylan |
1615 | Phendimetrazine | stimulant | III | N | Plegine, Prelu-2, Bontril, Melfiat, Statobex |
1631 | Phenmetrazine | stimulant | II | N | Preludin |
2285 | Phenobarbital | depressant | IV | N | Luminal, Bellergal-S |
9647 | Phenomorphan | opioid | I | Y | |
9641 | Phenoperidine | opioid | I | Y | Operidine, Lealgin |
1640 | Phentermine | stimulant | IV | N | Ionamin, Fastin, Adipex-P, Obe-Nix, Zantryl |
9841 | Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide; also known as benzoyl fentanyl) | opioid | I | Y | |
8501 | Phenylacetone | precursor | II | N | P2P, phenyl-2-propanone, benzyl methyl ketone |
9314 | Pholcodine | cannabimimetic agent | I | Y | Copholco, Adaphol, Codisol, Lantuss, Pholcolin |
9730 | Piminodine | opioid | II | Y | |
2883 | Pinazepam | depressant | IV | N | Domar |
1750 | Pipradrol | stimulant | IV | N | Detaril, Stimolag Fortis |
9642 | Piritramide | opioid | I | Y | Piridolan |
9650 | Poppy Straw | II | Y | Opium poppy capsules, poppy heads | |
9670 | Poppy Straw Concentrate | opioid | II | Y | Concentrate of Poppy Straw, CPS |
2764 | Prazepam | depressant | IV | N | Centrax |
2782 | Pregabalin | other | V | N | Lyrica |
9643 | Proheptazine | opioid | I | Y | |
9644 | Properidine | opioid | I | Y | |
9649 | Propiram | opioid | I | Y | Algeril |
4000 | prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole) | steroid | III | N | Prostanozol; |
9759 | Protonitazene (N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine) | I | Y | ||
7437 | Psilocybin | hallucinogen | I | N | Constituent of "Magic mushrooms" |
7438 | Psilocyn | hallucinogen | I | N | Psilocin, constituent of "Magic mushrooms" (Positional Isomers: 6-hydroxy DMT; 7-hydroxy DMT) |
1485 | Pyrovalerone | stimulant | V | N | Centroton, Thymergix |
2881 | Quazepam | depressant | IV | N | Doral |
9732 | Racemethorphan | opioid | II | Y | |
9645 | Racemoramide | opioid | I | Y | |
9733 | Racemorphan | opioid | II | Y | Dromoran |
9739 | Remifentanil | opioid | II | Y | Ultiva |
2846 | Remimazolam (4H-imidazol[1,2-a][1,4]benzodiazepine-4-propionic acid) | depressant | IV | N | 8-bromo-1-methyl-6-(2-pyridinyl)-(4S)-methyl ester, benzenesulfonate (1:1) and also, methyl 3-[(4S)-8- bromo-1-methyl-6-pyridin-2-yl-4H-imidazo[1,2- a][1,4]benzodiazepin- 4yl]propanoate benzenesulfonic acid |
2315 | Secobarbital | depressant | II | N | Seconal, Tuinal |
2316 | Secobarbital & noncontrolled active ingred | III | N | ||
2316 | Secobarbital suppository dosage form | III | N | ||
1729 | Serdexmethylphenidate | stimulant | IV | N | |
1675 | Sibutramine | stimulant | IV | N | Meridia |
1650 | Solriamfetol (2-amino-3-phenylpropyl car-bamate;benzenepropanol, beta-amino-, carbamate (ester)) | stimulant | IV | N | |
1635 | SPA | stimulant | IV | N | 1-dimethylamino-1,2-diphenylethane, Lefetamine |
7008 | SR-18 (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl)indole) | cannabimimetic agent | I | N | SR-18 and RCS-8 |
7104 | SR-19 (1-Pentyl-3-[(4-methoxy)-benzoyl] indole | cannabimimetic agent | I | N | SR-19 and RCS-4 |
4000 | stanozolol (17α-methyl-17β-hydroxy-5α-androst-2-eno[3,2-c]-pyrazole) | steroid | III | N | Winstrol, Winstrol-V |
4000 | stenbolone (17β-hydroxy-2-methyl-5α-androst-1-en-3-one) | steroid | III | N | |
1405 | Stimulant compounds previously excepted | stimulant | III | N | Mediatric |
9740 | Sufentanil | opioid | II | Y | Sufenta |
2600 | Sulfondiethylmethane | depressant | III | N | |
2605 | Sulfonethylmethane | depressant | III | N | |
2610 | Sulfonmethane | depressant | III | N | |
2223 | Suvorexant | depressant | IV | N | MK-4305, [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7- methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3- triazol-2-yl)phenyl]methanone |
2100 | Talbutal | depressant | III | N | Lotusate |
9780 | Tapentadol | opioid | II | Y | |
2925 | Temazepam | depressant | IV | N | Restoril |
4000 | testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid lactone) | steroid | III | N | Teolit, Teslac |
4000 | testosterone (17β-hydroxyandrost-4-en-3-one) | steroid | III | N | Android-T, Androlan, Depotest, Delatestryl |
7370 | Tetrahydrocannabinols | hallucinogen | I | N | THC, Delta-8 THC, Delta-9 THC, dronabinol and others |
4000 | tetrahydrogestrinone (13β,17α-diethyl-17β-hydroxygon-4,9,11-trien-3-one) | steroid | III | N | THG |
2886 | Tetrazepam | depressant | IV | N | Myolastan, Musaril |
9315 | Thebacon | cannabimimetic agent | I | Y | Acetylhydrocodone, Acedicon, Thebacetyl |
9333 | Thebaine | opioid | II | Y | Precursor of many narcotics |
9729 | Thiafentanil | opioid | II | Y | Thianil |
2100 | Thiamylal | depressant | III | N | Surital |
9835 | Thiofentanyl | opioid | I | Y | Chine white, fentanyl |
9839 | Thiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide; also known as 2-thiofuranyl fentanyl; thiophene fentanyl) | opioid | I | Y | |
2100 | Thiopental | depressant | III | N | Pentothal |
7024 | THJ-2201 [1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone | cannabimimetic agent | I | N | THJ-2201 |
7295 | Tiletamine & Zolazepam Combination Product | depressant | III | N | Telazol |
9750 | Tilidine | opioid | I | Y | Tilidate, Valoron, Kitadol, Lak, Tilsa |
9752 | Tramadol (2-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol) | narcotic | IV | Y | Tramadol |
4000 | trenbolone (17β-hydroxyestr-4,9,11-trien-3-one) | steroid | III | N | Finaplix-S, Finajet, Parabolan |
2887 | Triazolam | depressant | IV | N | Halcion |
9646 | Trimeperidine | opioid | I | Y | Promedolum |
9547 | U-47700 (3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide) | opioid | I | Y | U-47700 |
7144 | UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)metanone | cannabimimetic agent | I | N | UR-144 |
9840 | Valeryl fentanyl | opioid | I | Y | N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide |
2100 | Vinbarbital | depressant | III | N | Delvinal, vinbarbitone |
2781 | Zaleplon | depressant | IV | N | Sonata |
9873 | Zipeprol (1-methoxy-3[-4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-phenylpropan-2-ol) | opioid | I | Y | |
2783 | Zolpidem | depressant | IV | N | Ambien, Ivadal, Stilnoct, Stilnox |
2784 | Zopiclone | depressant | IV | N | Lunesta |
2420 | Zuranolone | depressant | IV | N | ZURZUVAE |
4000 | [3,2-c]-furazan-5α-androstan-17β-ol | steroid | III | N | |
4000 | [3,2-c]pyrazole-androst-4-en-17β-ol | steroid | III | N | |
7551 | α-PiHP (4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one) | stimulant | I | N | α-PiHP; alpha-PiHP |
4000 | Δ1-dihydrotestosterone (17β-hydroxy-5α-androst-1-en-3-one) | steroid | III | N | 1-Testosterone |
Thank you for choosing Find-A-Code, please Sign In to remove ads.